Q3 2021 13F Holders as of 30 Sep 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
108M
-
Number of holders
-
354
-
Total 13F shares, excl. options
-
62.2M
-
Shares change
-
+438K
-
Total reported value, excl. options
-
$8.34B
-
Value change
-
+$38.2M
-
Put/Call ratio
-
1.02
-
Number of buys
-
191
-
Number of sells
-
-150
-
Price
-
$134.15
Significant Holders of Intellia Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NTLA) as of Q3 2021
429 filings reported holding NTLA - Intellia Therapeutics, Inc. - Common Stock, par value $0.0001 per share as of Q3 2021.
Intellia Therapeutics, Inc. - Common Stock, par value $0.0001 per share (NTLA) has 354 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 62.2M shares
of 108M outstanding shares and own 57.68% of the company stock.
Largest 10 shareholders include ARK Investment Management LLC (6.74M shares), VANGUARD GROUP INC (6.35M shares), BlackRock Inc. (5.53M shares), FMR LLC (3.18M shares), Nikko Asset Management Americas, Inc. (2.4M shares), Sumitomo Mitsui Trust Holdings, Inc. (2.4M shares), PRICE T ROWE ASSOCIATES INC /MD/ (2.34M shares), STATE STREET CORP (1.66M shares), VIKING GLOBAL INVESTORS LP (1.28M shares), and ALLIANCEBERNSTEIN L.P. (1.24M shares).
This table shows the top 354 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.